Exact Sciences Acquires Thrive Earlier Detection
After over a year away from the healthcare M&A market, Exact Sciences Corp. (NYSE: EXAS) is back with a new acquisition. Last week, the company announced it purchased Cambridge, Massachusetts-based Thrive Earlier Detection Corp., a healthcare company focused on incorporating earlier cancer detection into routine medical care. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease. Under the terms of the agreement, Exact Science will pay $1.7 billion at closing, consisting of Exact Sciences common stock and 35% in cash. An additional $450 million would be payable based upon the achievement of certain milestones.... Read More »
Innovative Renal Care Acquires American Renal Associates
Innovative Renal Care, a portfolio company of Nautic Partners, has significantly expanded its network through a new acquisition. The dialysis provider has added American Renal Associates Holdings, Inc. (NYSE: ARA) for $853 million, or $11.50 per share in cash, representing an approximate premium of 66% to the company’s closing price on October 1, 2020. The price includes net debt. ARA is a leading provider of outpatient dialysis services in the United States. As of June 30, 2020, ARA operated 251 dialysis clinic locations in 27 states and the District of Columbia serving more than 17,300 patients with end-stage renal disease. ARA generated 12-month revenues of $815.8 million with EBITDA of... Read More »
Ampersand Capital Partners Strikes Two Deals
Ampersand Capital Partners, a middle-market private equity firm, had a busy week, announcing two deals back to back. On September 21, the company revealed it acquired GeneWerk GmbH and American Laboratory Products Company, Ltd. for an undisclosed sum. Based in Heidelberg, Germany, GeneWerk GmbH is a cell and gene therapy testing laboratory focused on providing preclinical and clinical trial patient sample analysis services. The company is recognized as a leading provider of vector integration site analysis (ISA) services, a method that was developed by the company’s founders and that the FDA and European Medicines Agency recommend performing after the administration of both... Read More »
Kai Medical Labs Acquired by Empower Clinics to Ramp Up COVID Testing
Empower Clinics Inc., a vertically integrated health and wellness company, has jumped into the healthcare M&A market. Last week, the company acquired Kai Medical Laboratory, LLC for an undisclosed sum. Kai Medical Laboratory is a high-complexity CLIA- and COLA-accredited laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory is located in Dallas, Texas. The deal includes an 8,000-square-foot medical laboratory including a covered drive-up testing center with premium testing and laboratory equipment, cash and current assets all with a combined value in excess of $1.75 million. Kai Medical... Read More »
Sonde Health Buys NeurLex to Boost Voice Science Platform
Last week, Boston-based Sonde Health acquired NeuroLex Laboratories, Inc. to expand its voice-based technology platform. Sonde’s proprietary platform detects symptoms of health conditions, such as depression and respiratory disease, from changes in voice. Using machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring. Sone Health has 300,000 voice samples from over 50,000 individuals. The data is especially useful in the fields of psychosis and related psychiatric treatment. NeuroLex Labs offers highly complementary services. It also uses speech analysis to detect various health... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
